The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study.
 
Kelly C. Goldsmith
No Relationships to Disclose
 
Yael P. Mosse
Consulting or Advisory Role - ASCO; Auron Therapeutics; Jumo Health; Lilly; Pfizer
Research Funding - Pfizer
 
Kimberly Kayser
No Relationships to Disclose
 
Yueh-Yun Chi
No Relationships to Disclose
 
Marc Chioda
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Pfizer
 
Holger C. Thurm
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Joseph Chen
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Sriram Krishnaswami
Employment - Pfizer
Leadership - Pfizer
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - Pfizer
Patents, Royalties, Other Intellectual Property - Pfizer
Travel, Accommodations, Expenses - Pfizer
 
Gerson Peltz
Employment - Pfizer; Reata Pharmaceuticals
Stock and Other Ownership Interests - Pfizer; Reata Pharmaceuticals
 
Meaghan Granger
No Relationships to Disclose
 
Rajen Mody
No Relationships to Disclose
 
Lynley V. Marshall
No Relationships to Disclose
 
Ami Vijay Desai
Stock and Other Ownership Interests - Pfizer; Viatris
Consulting or Advisory Role - Ology Medical Education; Ymabs Therapeutics Inc
Research Funding - Actuate Therapeutics (Inst); GlaxoSmithKline (Inst); Jubilant DraxImage (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Ymabs Therapeutics Inc (Inst)
 
Esther Berko
No Relationships to Disclose
 
John M. Maris
Stock and Other Ownership Interests - Tantigen Bio
Consulting or Advisory Role - Auron Therapeutics; Illumina Radiopharmaceuticals; Jubilant DraxImage
Patents, Royalties, Other Intellectual Property - GPC2 binders and CARs (Inst); Neuroblastoma antigens (Inst)
 
Katherine K. Matthay
Consulting or Advisory Role - Innervate RAdiopharmaceuticals; Resonance
 
Suzy Ghazarian
No Relationships to Disclose
 
Julie R. Park
No Relationships to Disclose
 
Araz Marachelian
Research Funding - Pfizer (Inst); United Therapeutics (Inst)